Table 2 Antibiotic prescriptions GP (at first consultation) of M. pneumoniae positive patients with successful macrolide resistance marker analysis.

From: Mycoplasma pneumoniae MLST detected in the upsurge of pneumonia during the 2023 to 2024 winter season in the Netherlands

 

GP

CAP

OARI

N = 43

N = 13

Amoxicillin

26 (60%)

2 (15%)

Azithromycin

3 (7%)

0

Doxycycline

4 (9%)

0

None reported

10 (23%)

11 (85%)